Liquid Biopsy | Tissuepathology.com

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors

Erica Goodpaster — Wed, 04 Jan 2023 12:53:45 +0000

The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible. A prospective, blinded study by a research team at the Imperial College, London showed very high accuracy in detecting malignant brain tumors. Datar Cancer Genetics now has three Breakthrough Designations granted by the USFDA, including […]

The post US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors first appeared on Tissuepathology.com.

Personalis, UCSF Look to Circulating Tumor DNA for Treatment Response Biomarkers

Erica Goodpaster — Tue, 20 Dec 2022 14:16:16 +0000

December 15, 2022 | Personalis and the University of California, San Francisco (UCSF) have announced a collaboration that will deploy a personalized liquid biopsy-based research use only (RUO) assay for a study of patients with colorectal cancer. The research efforts will use Personalis’ NeXT Personal assay to evaluate circulating tumor DNA (ctDNA)-based signatures associated with treatment […]

The post Personalis, UCSF Look to Circulating Tumor DNA for Treatment Response Biomarkers first appeared on Tissuepathology.com.

nRichDX Launches Two New Products for Liquid Biopsy Applications

Erica Goodpaster — Tue, 25 Oct 2022 11:32:45 +0000

nRichDX: The Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit™ and cfDNA Reference Standard products are designed to advance liquid biopsy application development. IRVINE, Calif., October 24, 2022 – nRichDX® has launched two new products designed to help researchers advance liquid biopsy assay development. Both products are designed for use with nRichDX’s Revolution Sample Prep System™. nRichDX’s Revolution […]

The post nRichDX Launches Two New Products for Liquid Biopsy Applications first appeared on Tissuepathology.com.

Quest Links Up With Paige For AI-powered Cancer Pathology Tests

Erica Goodpaster — Wed, 26 May 2021 13:19:28 +0000

To help build out its own portfolio of artificial-intelligence-driven pathology tests, Quest Diagnostics has enlisted the help of Paige to develop a suite of products aimed at individual clinical oncologists as well as larger biopharma companies and their R&D efforts. The collaboration will start with the diagnosis of solid tumors—including cancers of the prostate, breast, […]

The post Quest Links Up With Paige For AI-powered Cancer Pathology Tests first appeared on Tissuepathology.com.

Remote Intraoperative Margin Assessment & Bedside Diagnostics

Dr. Keith J. Kaplan — Wed, 15 Apr 2020 17:56:02 +0000

Pathologist Logs into OR Image Acquisition CLICK HERE for Dr. Krishnamurthy of MD Anderson Study Bedside Diagnostics for Breast Cancer in JAMA Contact CaliberID for Remote Demo Source: CaliberID

The post Remote Intraoperative Margin Assessment & Bedside Diagnostics first appeared on Tissuepathology.com.

Scottish Virtual Human Tissue Biobank Plays Vital Role in COVID-19 Fight

Dr. Keith J. Kaplan — Fri, 03 Apr 2020 16:43:18 +0000

A Scotland-based virtual biobank dealing in ethically sourced human tissue samples is helping to speed up the provision of COVID-19 samples for researchers and drug developers working to find a cure for the global pandemic. Tissue Solutions Ltd, founded in 2007, responded to the UKCRC Tissue Directory and Coordination Centre’s (TDCC) call to action in […]

The post Scottish Virtual Human Tissue Biobank Plays Vital Role in COVID-19 Fight first appeared on Tissuepathology.com.